Sandip I. Patel

Insider Reports History

Location
C/O Quantum Fintech Acquisition Corp, 4221 W. Boy Scout Blvd., Suite 300, Tampa, FL
Signature
/s/ Torsten Hombeck, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sandip I. Patel:

Stock Role Class Num Shares Value Price $ Report Date Ownership
AtlasClear Holdings, Inc. Director Common Stock 243K $1.13M $4.64 Feb 9, 2024 Direct
Akari Therapeutics Plc Director Ordinary Shares, par value $0.0001 per share 904M $1.08M $0.00 Nov 14, 2024 Direct
Akari Therapeutics Plc Director American Depositary Shares representing Ordinary Shares 452K $506K $1.12 Mar 20, 2025 Direct
Akari Therapeutics Plc Director Series A Warrants (Right to Buy) 44.6K $50K $1.12 Mar 6, 2025 Direct
Akari Therapeutics Plc Director Series B Warrants (Right to Buy) 44.6K $50K $1.12 Mar 6, 2025 Direct
Akari Therapeutics Plc Director Ordinary Shares, par value $0.0001 per share 40.4M $48.5K $0.00 Nov 14, 2024 By Davis Island Ventures LLC
Akari Therapeutics Plc Director Ordinary Shares, par value $0.0001 per share 39.8M $47.7K $0.00 Nov 14, 2024 By Quest Bio LLC
Akari Therapeutics Plc Director Ordinary Shares, par value $0.0001 per share 27.8M $33.4K $0.00 Nov 14, 2024 By Innovative Lifesci Investments LLC
Akari Therapeutics Plc Director American Depositary Shares representing Ordinary Shares 20.2K $22.6K $1.12 Apr 25, 2025 Davis Island Ventures LLC
Akari Therapeutics Plc Director American Depositary Shares representing Ordinary Shares 19.9K $22.3K $1.12 Apr 25, 2025 Quest Bio LLC
Akari Therapeutics Plc Director American Depositary Shares representing Ordinary Shares 13.9K $15.6K $1.12 Mar 20, 2025 Innovative Lifesci Investment LLC
Akari Therapeutics Plc Director Ordinary Shares, par value $0.0001 per share 12.5M $15K $0.00 Nov 14, 2024 By TT Insurance Investment LLC
Akari Therapeutics Plc Director American Depositary Shares representing Ordinary Shares 6.25K $7K $1.12 Apr 25, 2025 TT Insurance Investment LLC
Peak Bio, Inc. Director Common Stock 0 $0 $0.27 Nov 14, 2024 Direct
Peak Bio, Inc. Director Common Stock 0 $0 $0.27 Nov 14, 2024 Indirect
Monterey Innovation Acquisition Corp Director, 10%+ Owner Common Stock 1.42M Mar 9, 2023 Indirect
AtlasClear Holdings, Inc. Director Warrants 354K Mar 20, 2024 Direct
Akari Therapeutics Plc Director Stock Option (Right to Buy) 225K Mar 20, 2025 Direct
Monterey Innovation Acquisition Corp Director, 10%+ Owner Common Stock 35K Mar 9, 2023 Direct
Akari Therapeutics Plc Director American Depositary Shares representing Ordinary Shares 13.9K Apr 25, 2025 Innovative Lifesci Investments LLC
Peak Bio, Inc. Director Convertible Notes 0 Nov 14, 2024 Direct
Peak Bio, Inc. Director Stock Option (Right to Buy) 0 Nov 14, 2024 Direct
Quantum FinTech Acquisition Corp Director Common Stock 0 Feb 9, 2024 Direct

Insider Reports Filed by Sandip I. Patel

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AKTX Akari Therapeutics Plc Apr 25, 2025 3 $150K 4 Apr 29, 2025 Director
AKTX Akari Therapeutics Plc Mar 20, 2025 2 $0 4 Mar 24, 2025 Director
AKTX Akari Therapeutics Plc Nov 14, 2024 0 $0 3 Nov 22, 2024 Director
PKBO Peak Bio, Inc. Nov 14, 2024 7 -$276K 4 Nov 18, 2024 Director
ATCH AtlasClear Holdings, Inc. Feb 9, 2024 2 $0 4 Apr 16, 2024 Director
ATCH AtlasClear Holdings, Inc. Feb 9, 2024 0 $0 3 Apr 16, 2024 Director
QFTA Quantum FinTech Acquisition Corp Feb 9, 2024 1 $0 4 Feb 16, 2024 Director
MTRY Monterey Innovation Acquisition Corp Mar 9, 2023 2 -$3.42K 4 Mar 13, 2023 Director, 10%+ Owner
MTRY Monterey Bio Acquisition Corp Sep 30, 2021 0 $0 3 Sep 30, 2021 Director, 10%+ Owner